Breaking News Bar
updated: 10/2/2012 9:34 AM

CORPAK acquires Merck Serono's U.K. sales, distribution

hello
Success - Article sent! close
 
Marketwire

BUFFALO GROVE -- CORPAK MedSystems, Inc., said it will acquire the gastroenterology sales and distribution operation of Merck Serono Limited in the U.K. and Ireland.

Merck Serono had previously served as CORPAK's distribution partner for the region.

Order Reprint Print Article
 
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.
Need more information about reprints? Visit our Reprints Section for more details.

Contact information ( * required )

Success - request sent close

"The acquisition of the Merck Serono gastroenterology business strengthens our presence in Europe and our direct operation will support high levels of customer service and continued growth," said Tom Kuhn, president of CORPAK. "I would like to thank the employees at Merck Serono for their support in building the CORPAK business in the UK and Republic of Ireland."

There will be no change to the product range and all CORPAK products will continue to be available on the current codes and prices. The acquisition keeps relationships with existing sub-distributors unchanged.

"We are especially pleased to be able to welcome the gastroenterology employees from Merck Serono to the CORPAK family," says Jeff Blair, CEO of CORPAK. "We are confident that the U.K. and Ireland team will continue the history of excellence and dedication that has benefitted our customers in the past."

Eric Larson, Chairman of the CORPAK Board. said the acquisition "represents an important step in expanding our international presence and we look forward to continuing to provide our innovative, quality products to the European market."

Share this page
Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.